Volume 596 Issue 7871, 12 August 2021
Article | 08 July 2021
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
The SARS-CoV-2 Delta variant partially evades neutralization by several monoclonal antibodies and by sera from individuals who have had COVID-19, but two doses of anti-COVID-19 vaccines still generate a strong neutralizing response.
Delphine Planas, David Veyer, Olivier Schwartz